Evidence Details for EPHB3
Basic Information Top
Gene Symbol: | EPHB3 ( ETK2,HEK2,TYRO6 ) |
---|---|
Gene Full Name: | EPH receptor B3 |
Band: | 3q27.1 |
Quick Links | Entrez ID:2049; OMIM: 601839; Uniprot ID:EPHB3_HUMAN; ENSEMBL ID: ENSG00000182580; HGNC ID: 3394 |
Relate to Another Database: | SFARIGene; denovo-db |
Sequences Top
>EPHB3|2049|nucleotide
ATGGCCAGAGCCCGCCCGCCGCCGCCGCCGTCGCCGCCGCCGGGGCTTCTGCCGCTGCTCCCTCCGCTGCTGCTGCTGCCGCTGCTGCTGCTGCCCGCCGGCTGC
CGGGCGCTGGAAGAGACCCTCATGGACACAAAATGGGTAACATCTGAGTTGGCGTGGACATCTCATCCAGAAAGTGGGTGGGAAGAGGTGAGTGGCTACGATGAG
GCCATGAATCCCATCCGCACATACCAGGTGTGTAATGTGCGCGAGTCAAGCCAGAACAACTGGCTTCGCACGGGGTTCATCTGGCGGCGGGATGTGCAGCGGGTC
TACGTGGAGCTCAAGTTCACTGTGCGTGACTGCAACAGCATCCCCAACATCCCCGGCTCCTGCAAGGAGACCTTCAACCTCTTCTACTACGAGGCTGACAGCGAT
GTGGCCTCAGCCTCCTCCCCCTTCTGGATGGAGAACCCCTACGTGAAAGTGGACACCATTGCACCCGATGAGAGCTTCTCGCGGCTGGATGCCGGCCGTGTCAAC
ACCAAGGTGCGCAGCTTTGGGCCACTTTCCAAGGCTGGCTTCTACCTGGCCTTCCAGGACCAGGGCGCCTGCATGTCGCTCATCTCCGTGCGCGCCTTCTACAAG
AAGTGTGCATCCACCACCGCAGGCTTCGCACTCTTCCCCGAGACCCTCACTGGGGCGGAGCCCACCTCGCTGGTCATTGCTCCTGGCACCTGCATCCCTAACGCC
GTGGAGGTGTCGGTGCCACTCAAGCTCTACTGCAACGGCGATGGGGAGTGGATGGTGCCTGTGGGTGCCTGCACCTGTGCCACCGGCCATGAGCCAGCTGCCAAG
GAGTCCCAGTGCCGCCCCTGTCCCCCTGGGAGCTACAAGGCGAAGCAGGGAGAGGGGCCCTGCCTCCCATGTCCCCCCAACAGCCGTACCACCTCCCCAGCCGCC
AGCATCTGCACCTGCCACAATAACTTCTACCGTGCAGACTCGGACTCTGCGGACAGTGCCTGTACCACCGTGCCATCTCCACCCCGAGGTGTGATCTCCAATGTG
AATGAAACCTCACTGATCCTCGAGTGGAGTGAGCCCCGGGACCTGGGTGGCCGGGATGACCTCCTGTACAATGTCATCTGCAAGAAGTGCCATGGGGCTGGAGGG
Show »
ATGGCCAGAGCCCGCCCGCCGCCGCCGCCGTCGCCGCCGCCGGGGCTTCTGCCGCTGCTCCCTCCGCTGCTGCTGCTGCCGCTGCTGCTGCTGCCCGCCGGCTGC
CGGGCGCTGGAAGAGACCCTCATGGACACAAAATGGGTAACATCTGAGTTGGCGTGGACATCTCATCCAGAAAGTGGGTGGGAAGAGGTGAGTGGCTACGATGAG
GCCATGAATCCCATCCGCACATACCAGGTGTGTAATGTGCGCGAGTCAAGCCAGAACAACTGGCTTCGCACGGGGTTCATCTGGCGGCGGGATGTGCAGCGGGTC
TACGTGGAGCTCAAGTTCACTGTGCGTGACTGCAACAGCATCCCCAACATCCCCGGCTCCTGCAAGGAGACCTTCAACCTCTTCTACTACGAGGCTGACAGCGAT
GTGGCCTCAGCCTCCTCCCCCTTCTGGATGGAGAACCCCTACGTGAAAGTGGACACCATTGCACCCGATGAGAGCTTCTCGCGGCTGGATGCCGGCCGTGTCAAC
ACCAAGGTGCGCAGCTTTGGGCCACTTTCCAAGGCTGGCTTCTACCTGGCCTTCCAGGACCAGGGCGCCTGCATGTCGCTCATCTCCGTGCGCGCCTTCTACAAG
AAGTGTGCATCCACCACCGCAGGCTTCGCACTCTTCCCCGAGACCCTCACTGGGGCGGAGCCCACCTCGCTGGTCATTGCTCCTGGCACCTGCATCCCTAACGCC
GTGGAGGTGTCGGTGCCACTCAAGCTCTACTGCAACGGCGATGGGGAGTGGATGGTGCCTGTGGGTGCCTGCACCTGTGCCACCGGCCATGAGCCAGCTGCCAAG
GAGTCCCAGTGCCGCCCCTGTCCCCCTGGGAGCTACAAGGCGAAGCAGGGAGAGGGGCCCTGCCTCCCATGTCCCCCCAACAGCCGTACCACCTCCCCAGCCGCC
AGCATCTGCACCTGCCACAATAACTTCTACCGTGCAGACTCGGACTCTGCGGACAGTGCCTGTACCACCGTGCCATCTCCACCCCGAGGTGTGATCTCCAATGTG
AATGAAACCTCACTGATCCTCGAGTGGAGTGAGCCCCGGGACCTGGGTGGCCGGGATGACCTCCTGTACAATGTCATCTGCAAGAAGTGCCATGGGGCTGGAGGG
Show »
>EPHB3|2049|protein
MARARPPPPPSPPPGLLPLLPPLLLLPLLLLPAGCRALEETLMDTKWVTSELAWTSHPESGWEEVSGYDEAMNPIRTYQVCNVRESSQNNWLRTGFIWRRDVQRV
YVELKFTVRDCNSIPNIPGSCKETFNLFYYEADSDVASASSPFWMENPYVKVDTIAPDESFSRLDAGRVNTKVRSFGPLSKAGFYLAFQDQGACMSLISVRAFYK
KCASTTAGFALFPETLTGAEPTSLVIAPGTCIPNAVEVSVPLKLYCNGDGEWMVPVGACTCATGHEPAAKESQCRPCPPGSYKAKQGEGPCLPCPPNSRTTSPAA
SICTCHNNFYRADSDSADSACTTVPSPPRGVISNVNETSLILEWSEPRDLGGRDDLLYNVICKKCHGAGGASACSRCDDNVEFVPRQLGLTERRVHISHLLAHTR
YTFEVQAVNGVSGKSPLPPRYAAVNITTNQAAPSEVPTLRLHSSSGSSLTLSWAPPERPNGVILDYEMKYFEKSEGIASTVTSQMNSVQLDGLRPDARYVVQVRA
Show »
MARARPPPPPSPPPGLLPLLPPLLLLPLLLLPAGCRALEETLMDTKWVTSELAWTSHPESGWEEVSGYDEAMNPIRTYQVCNVRESSQNNWLRTGFIWRRDVQRV
YVELKFTVRDCNSIPNIPGSCKETFNLFYYEADSDVASASSPFWMENPYVKVDTIAPDESFSRLDAGRVNTKVRSFGPLSKAGFYLAFQDQGACMSLISVRAFYK
KCASTTAGFALFPETLTGAEPTSLVIAPGTCIPNAVEVSVPLKLYCNGDGEWMVPVGACTCATGHEPAAKESQCRPCPPGSYKAKQGEGPCLPCPPNSRTTSPAA
SICTCHNNFYRADSDSADSACTTVPSPPRGVISNVNETSLILEWSEPRDLGGRDDLLYNVICKKCHGAGGASACSRCDDNVEFVPRQLGLTERRVHISHLLAHTR
YTFEVQAVNGVSGKSPLPPRYAAVNITTNQAAPSEVPTLRLHSSSGSSLTLSWAPPERPNGVILDYEMKYFEKSEGIASTVTSQMNSVQLDGLRPDARYVVQVRA
Show »
Evidence summary Top
Click the link of the category-specific score to view different category of evidences. The categories without any evidences are hidden by default.
Evidences | Syndromic Gene | GWAS | CNV | Linkage | Association | Expression | NGS de novo | NGS Mosaic | NGS Other | Low-Scale Gene Studies | Total |
---|---|---|---|---|---|---|---|---|---|---|---|
Score (No. of Studies) | No | 0 (0) | 0 (0) | 1 (1) | 0 (1) | 0 (0) | 0 (1) | 0 (0) | 0 (1) | 0 (0) | 2 (4) |
Syndromic Autism Gene Top
Genome-Wide Association Studies(By Ethnic Group) Top
CNV Studies Top
Linkage Studies Top
Reference | Source | Method | ADI-R | ADOS | Diagnosis | Family | Individual | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total | Simplex | Multiplex | Control | Affected | Control | Total | ||||||
Allen-Brady, 2008 | - | SNP-based genomic screen | ASD | 1 | - | 1 | - | 7 | 22 | 29 |
Low Scale Association Studies (by Ethnic Group) Top
Family Based Association Studies: 1
Reference | Source | Platform | #Families | Affecteds | Result | |||||
---|---|---|---|---|---|---|---|---|---|---|
#Subjects (% Women) |
ADI-R | ADOS | Diagnosis | Age (range) |
IQ (range) |
|||||
CAUCASIAN | ||||||||||
Rehnstrom, 2008_1 | Finland | Sequenom iPLEX platform (Sequenom, San Diego,CA) | 97 | 118 (-) | AD | - - |
- - |
Case Control Based Association Studies: 0
Reference | Source | Platfrom | ASD Cases | Normal Controls | Result | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ADI-R | ADOS | Diagnosis | Age (range) |
IQ | #Subjects (% Women) |
Age (range) |
|||||
No Evidence. |
Large Scale Expression Studies Top
NGS de novo Mutation Studies Top
Reference | Case Number | Family Number | de novo Number | Title |
---|---|---|---|---|
Chen R, 2017 | 107 | 116 | 128 | Leveraging blood serotonin as an endophenotype to identify de novo and rare variants involved in aut |
NGS Mosaic SNV Studies Top
NGS Other Studies Top
Reference | Source | Platform | ADI-R | ADOS | Diagnosis | Family | Affected | Validation Method | ||
---|---|---|---|---|---|---|---|---|---|---|
Total | Simplex | Multiplex | ||||||||
Toma C, 2014 | - | Illumina HiSeq 2000 | - | - | ASD | 10 | - | - | 21 | - |
Low Scale Gene Studies Top
Contact Us if you are an author of a study regarding this gene and do not find your study in this table or find errors in the representation of your study details.